CKD患者维持性透析前已存在骨骼肌线粒体功能障碍
发现透析患者和未透析CKD患者的磷酸肌酸恢复时间常数均较对照组延长,且线粒体功能障碍与体能差、肌间脂肪浸润及炎症氧化应激标志物升高相关。结论认为线粒体功能障碍由多因素导致,在CKD 3-5期即已出现。
要点
- CKD 3-5期未透析患者已存在骨骼肌线粒体功能障碍。
- 线粒体功能障碍与体能下降、肌间脂肪增多和炎症氧化应激相关。
- 维持性透析患者骨骼肌出现线粒体碎片化及DRP1含量增加。
核心结论
- 线粒体功能障碍由多因素病因导致,且在维持性血液透析开始前即已存在,包括CKD 3-5期患者。
研究设计与样本
- 采用31P磁共振波谱获取磷酸肌酸恢复时间常数以评估在体膝关节伸肌线粒体功能。
- 使用6分钟步行试验评估体能,磁共振成像评估肌间脂肪浸润,并检测血浆炎症和氧化应激标志物。
- 在部分维持性血液透析患者的骨骼肌活检中检测线粒体动力学(融合与分裂)标志物。
主要发现
- 维持性血液透析患者磷酸肌酸恢复时间常数为53.3(43.4-70.1)秒,CKD未透析患者为41.5(35.4-49.1)秒,均较对照组38.9(32.5-46.0)秒延长(组间P=0.001)。
- 线粒体功能障碍与体能差相关(r=0.62;P=0.001),与肌间脂肪增多相关(r=0.44;P=0.001),与炎症和氧化应激标志物升高相关(r=0.60;P=0.001)。
- 维持性血液透析患者骨骼肌出现线粒体碎片化,动力相关蛋白1含量为0.86(0.48-1.35)任意单位,高于对照组的0.60(0.24-0.75)任意单位。
临床怎么用
- 对于CKD 3-5期未透析患者,应关注骨骼肌线粒体功能作为预防衰弱和肌少症的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Patients with CKD suffer from frailty and sarcopenia, which is associated with higher morbidity and mortality. Skeletal muscle mitochondria are important for physical function and could be a target to prevent frailty and sarcopenia. In this study, we tested the hypothesis that mitochondrial dysfunction is associated with the severity of CKD. We also evaluated the interaction between mitochondrial function and coexisting comorbidities, such as impaired physical performance, intermuscular adipose tissue infiltration, inflammation, and oxidative stress. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Sixty-three participants were studied, including controls (n=21), patients with CKD not on maintenance hemodialysis (CKD 3-5; n=20), and patients on maintenance hemodialysis (n=22). We evaluated in vivo knee extensors mitochondrial function using 31P magnetic resonance spectroscopy to obtain the phosphocreatine recovery time constant, a measure of mitochondrial function. We measured physical performance using the 6-minute walk test, intermuscular adipose tissue infiltration with magnetic resonance imaging, and markers of inflammation and oxidative stress in plasma. In skeletal muscle biopsies from a select number of patients on maintenance hemodialysis, we also measured markers of mitochondrial dynamics (fusion and fission). RESULTS: We found a prolonged phosphocreatine recovery constant in patients on maintenance hemodialysis (53.3 [43.4-70.1] seconds, median [interquartile range]) and patients with CKD not on maintenance hemodialysis (41.5 [35.4-49.1] seconds) compared with controls (38.9 [32.5-46.0] seconds; P=0.001 among groups). Mitochondrial dysfunction was associated with poor physical performance (r=0.62; P=0.001), greater intermuscular adipose tissue (r=0.44; P=0.001), and increased markers of inflammation and oxidative stress (r=0.60; P=0.001). We found mitochondrial fragmentation and increased content of dynamin-related protein 1, a marker of mitochondrial fission, in skeletal muscles from patients on maintenance hemodialysis (0.86 [0.48-1.35] arbitrary units (A.U.), median [interquartile range]) compared with controls (0.60 [0.24-0.75] A.U.). CONCLUSIONS: Mitochondrial dysfunction is due to multifactorial etiologies and presents prior to the initiation of maintenance hemodialysis, including in patients with CKD stages 3-5.
引用
- Gamboa JL, Roshanravan B, Towse T, et al. Skeletal Muscle Mitochondrial Dysfunction Is Present in Patients with CKD before Initiation of Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2020. PMID: 32591419. doi:10.2215/CJN.10320819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。